SCHEMBL14545832

SCHEMBL14545832

Bc1cnn2c(NCCNC(=O)c3ccccc3Cl)cc(-c3ccccc3Cl)nc12

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 4/20 0.48
▸ ALDH1A1 P00352 3/20 0.46
▸ LMNA P02545 1/20 0.46
▸ GSK3B P49841 4/20 0.46
▸ MAPT P10636 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ BRD4 O60885 1/20 0.41
▸ SMYD2 Q9NRG4 1/20 0.40
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ UBE2N P61088 1/20 0.39
▸ HPGD P15428 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14545834 0.90 GSK3B (0.44) CDK2ALDH1A1GSK3BMAPK1L3MBTL1
SCHEMBL13288897 0.90 CDK2 (0.43) CDK2ALDH1A1LMNAGSK3BMAPT
SCHEMBL13120245 0.89 CDK2 (0.62) CDK2ALDH1A1LMNAGSK3BMAPT
SCHEMBL13288854 0.88 GSK3B (0.48) CDK2GSK3BSMN1; SMN2
SCHEMBL13288754 0.87 CDK2 (0.45) CDK2LMNAGSK3BMAPTNPC1
SCHEMBL14545970 0.87 GSK3B (0.45) CDK2GSK3B
SCHEMBL13288895 0.87 GSK3B (0.43) CDK2ALDH1A1LMNAGSK3BMAPT
SCHEMBL14545261 0.86 CDK2 (0.53) CDK2LMNAGSK3BMAPTNPC1
SCHEMBL13289308 0.86 CDK2 (0.53) CDK2ALDH1A1GSK3BMAPTMAPK1
SCHEMBL13288867 0.86 CDK2 (0.47) CDK2GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007044449-A2 NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2007-04-19 — — WO disclosed
Send feedback